Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06037811
Status:
RECRUITING
Last Update Posted:
2024-03-13
First Post:
2023-08-31
Brief Title:
Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
Sponsor:
Tom Appleton
Organization:
Lawson Health Research Institute
Organization Data
Organization:
Lawson Health Research Institute
Class:
OTHER
Study ID:
CanRIO ADA2023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tom Appleton
Lead Sponsor Class:
OTHER
Responsible Party:
Tom Appleton
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Lawson Health Research Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Canadian Research Group in Immuno-Oncology | UNKNOWN |
| Western University | OTHER |